BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 38692143)

  • 1. Post-surgery statin use contributes to favorable outcomes in patients with early breast cancer.
    Giorello MB; Marks MP; Osinalde TM; Padin MDR; Wernicke A; Calvo JC; Chasseing NA; Vellón L
    Cancer Epidemiol; 2024 Jun; 90():102573. PubMed ID: 38692143
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The target for statins, HMG-CoA reductase, is expressed in ductal carcinoma-in situ and may predict patient response to radiotherapy.
    Butt S; Butt T; Jirström K; Hartman L; Amini RM; Zhou W; Wärnberg F; Borgquist S
    Ann Surg Oncol; 2014 Sep; 21(9):2911-9. PubMed ID: 24777857
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Treatment outcomes and clinicopathologic characteristics of advanced triple-negative breast cancer patients].
    Zhang P; Xu BH; Ma F; Li Q; Yuan P; Wang JY; Zhang P
    Zhonghua Zhong Liu Za Zhi; 2011 May; 33(5):381-4. PubMed ID: 21875471
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The relationship between statins and breast cancer prognosis varies by statin type and exposure time: a meta-analysis.
    Liu B; Yi Z; Guan X; Zeng YX; Ma F
    Breast Cancer Res Treat; 2017 Jul; 164(1):1-11. PubMed ID: 28432513
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Management of the axilla in breast cancer: outcome analysis in a series of ductal versus lobular invasive cancers.
    Corona SP; Bortul M; Scomersi S; Bigal C; Bottin C; Zanconati F; Fox SB; Giudici F; Generali D
    Breast Cancer Res Treat; 2020 Apr; 180(3):735-745. PubMed ID: 32060782
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Statin use may improve clinicopathological characteristics and recurrence risk of invasive breast cancer.
    Sendur MA; Aksoy S; Yazıcı O; Ozdemir NY; Zengin N; Altundag K
    Med Oncol; 2014 Feb; 31(2):835. PubMed ID: 24381143
    [No Abstract]   [Full Text] [Related]  

  • 7. Impact of Time from Completion of Neoadjuvant Chemotherapy to Surgery on Survival Outcomes in Breast Cancer Patients.
    Sanford RA; Lei X; Barcenas CH; Mittendorf EA; Caudle AS; Valero V; Tripathy D; Giordano SH; Chavez-MacGregor M
    Ann Surg Oncol; 2016 May; 23(5):1515-21. PubMed ID: 26678405
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of concomitant statin treatment in postmenopausal patients with hormone receptor-positive early-stage breast cancer receiving adjuvant denosumab or placebo: a post hoc analysis of ABCSG-18.
    Minichsdorfer C; Fuereder T; Leutner M; Singer CF; Kacerovsky-Strobl S; Egle D; Greil R; Balic M; Fitzal F; Pfeiler G; Frantal S; Bartsch R; Gnant M
    ESMO Open; 2022 Apr; 7(2):100426. PubMed ID: 35334418
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Statin use in primary inflammatory breast cancer: a cohort study.
    Brewer TM; Masuda H; Liu DD; Shen Y; Liu P; Iwamoto T; Kai K; Barnett CM; Woodward WA; Reuben JM; Yang P; Hortobagyi GN; Ueno NT
    Br J Cancer; 2013 Jul; 109(2):318-24. PubMed ID: 23820253
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Surgical management of early breast cancer].
    Di GH; Wu J; Yu KD; Lu JS; Shen KW; Shen ZZ; Shao ZM
    Zhonghua Zhong Liu Za Zhi; 2007 Jan; 29(1):62-5. PubMed ID: 17575698
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HMG CoA reductase inhibitors (statins) for preventing acute kidney injury after surgical procedures requiring cardiac bypass.
    Lewicki M; Ng I; Schneider AG
    Cochrane Database Syst Rev; 2015 Mar; 2015(3):CD010480. PubMed ID: 25758322
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Statin prescriptions and breast cancer recurrence risk: a Danish nationwide prospective cohort study.
    Ahern TP; Pedersen L; Tarp M; Cronin-Fenton DP; Garne JP; Silliman RA; Sørensen HT; Lash TL
    J Natl Cancer Inst; 2011 Oct; 103(19):1461-8. PubMed ID: 21813413
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Influence of Statins and Cholesterol on Mortality Among Patients With Pancreatic Cancer.
    Huang BZ; Chang JI; Li E; Xiang AH; Wu BU
    J Natl Cancer Inst; 2017 May; 109(5):. PubMed ID: 28040693
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Removal of primary tumor improves survival in metastatic breast cancer. Does timing of surgery influence outcomes?
    Pérez-Fidalgo JA; Pimentel P; Caballero A; Bermejo B; Barrera JA; Burgues O; Martinez-Ruiz F; Chirivella I; Bosch A; Martínez-Agulló A; Lluch A
    Breast; 2011 Dec; 20(6):548-54. PubMed ID: 21816613
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Survival Outcomes for Patients With Clinical Complete Response After Neoadjuvant Chemotherapy: Is Omitting Surgery an Option?
    Özkurt E; Sakai T; Wong SM; Tukenmez M; Golshan M
    Ann Surg Oncol; 2019 Oct; 26(10):3260-3268. PubMed ID: 31342356
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 10 year survival after breast-conserving surgery plus radiotherapy compared with mastectomy in early breast cancer in the Netherlands: a population-based study.
    van Maaren MC; de Munck L; de Bock GH; Jobsen JJ; van Dalen T; Linn SC; Poortmans P; Strobbe LJA; Siesling S
    Lancet Oncol; 2016 Aug; 17(8):1158-1170. PubMed ID: 27344114
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Risk of Muscular Events Among New Users of Hydrophilic and Lipophilic Statins: an Observational Cohort Study.
    Mueller AM; Liakoni E; Schneider C; Burkard T; Jick SS; Krähenbühl S; Meier CR; Spoendlin J
    J Gen Intern Med; 2021 Sep; 36(9):2639-2647. PubMed ID: 33751411
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oncologic Safety of Immediate Breast Reconstruction in Breast Cancer Patients Who Underwent Neoadjuvant Chemotherapy: Short-Term Outcomes of a Matched Case-Control Study.
    Ryu JM; Park S; Paik HJ; Nam SJ; Kim SW; Lee SK; Yu J; Bae SY; Kim I; Bang SI; Mun GH; Pyon JK; Jeon BJ; Lee JE
    Clin Breast Cancer; 2017 Jun; 17(3):204-210. PubMed ID: 28065399
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Breast-conservation treatment for early invasive breast cancer: prognostic factors for survival after salvage treatment of local recurrence].
    Fodor J
    Magy Onkol; 2007; 51(2):127-31. PubMed ID: 17660868
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of the pleiotropic effect of atorvastatin and rosuvastatin on postmenopausal changes in bone turnover: A randomized comparative study.
    Braszak-Cymerman A; Walczak MK; Oduah MT; Ludziejewska A; Bryl W
    Medicine (Baltimore); 2024 May; 103(19):e38122. PubMed ID: 38728464
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.